FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay

Go back to FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay
(NASDAQ: NTRA) Delayed: 399.43 -13.95 (3.37%)
Previous Close $413.38    52 Week High $13.80 
Open $408.47    52 Week Low $6.52 
Day High $416.00    P/E N/A 
Day Low $395.00    EPS $0.00 
Volume 449,650